Medicine Description valcyte 450mg
Valcyte 450 mg 60 f.c. tab is a tablet manufactured by Roche that contains valganciclovir, an antiviral medication. Valganciclovir works by inhibiting the replication of certain viruses, particularly cytomegalovirus (CMV), making it effective in treating infections caused by this virus, especially in immunocompromised patients.
Indications and Uses of Valcyte 450 mg 60 f.c. tab
- Prevention of CMV disease in kidney transplant recipients
- Treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)
- Treatment of CMV infections in transplant patients
- Management of CMV disease in immunocompromised patients
How to Use Valcyte 450 mg 60 f.c. tab
- Swallow the tablet whole with a glass of water
- Take with food to enhance absorption
- Do not crush or chew the tablet
Contraindications of Valcyte 450 mg 60 f.c. tab
- Hypersensitivity to valganciclovir or ganciclovir
- Severe renal impairment
- Pregnancy unless the benefit outweighs the risk
- Breastfeeding
Drug Interactions
- Probenecid may increase the levels of valganciclovir
- Zidovudine may enhance the risk of myelosuppression
- Other antiviral medications may have additive effects
Side Effects of Valcyte 450 mg 60 f.c. tab
- Nausea
- Diarrhea
- Headache
- Anemia
- Neutropenia
- Thrombocytopenia
- Fever
Storage and Handling
Store at room temperature, away from light and moisture. Keep out of reach of children.
Warnings and Precautions
Patients should avoid driving if they experience drowsiness. Women who are pregnant or breastfeeding should consult their healthcare provider before use. Caution is advised when administering to elderly patients or children. Seek medical help if symptoms worsen or new symptoms appear.